Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

The Residency Seminar Committee presents:

12:30 pm - 1:20 pm, September 18, 2018

Patient Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS): A fresh breath for Inhaled Corticosteroids/Long-Acting Beta Agonists (ICS/LABA)?


Kristina Falk, PharmD
PGY-2 Ambulatory Care Pharmacy Resident
UIC College of Pharmacy

Live Presentation: UIC College of Pharmacy Chicago - Room 134-1

Live Broadcast: UIC College of Pharmacy Rockford - Room E211

Target Audience: Pharmacists

Learning Objectives:
At the completion of this activity, the participant will be able to:

• Describe barriers to providing guideline concordant asthma care in the US
• Define Patient Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS), Single maintenance and reliever therapy (SMART), single inhaler therapy (SiT), and intermittent inhaled corticosteroids (ICS) in the setting of asthma treatment
• Discuss the efficacy and safety of selected PARTICS strategy
• Explain the mechanism behind long-acting beta agonists (LABA) and inhaled corticosteroids (ICS) synergy
• Identify barriers to the implementations of Patient Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS) in the United States

Fees: There is no charge for attending this activity. 

Disclosure: Dr. Falk has no actual or potential conflicts of interest. Dr. Danziger is on the Speaker’s Bureau/Advisory Board for Allergan, The Medicines Company, and Merck. Dr. Anguiano is consultant for United Therapeutics HEOR and on the Speaker’s Bureau/ Advisory Board for United Therapeutics. Dr. Martin is a recipient of a grant/research support from Gilead and on the Speaker’s Bureau or Advisory Board for Gilead. Professor Moody is on the Speaker’s Bureau/Advisory Board for Shire Pharmaceuticals. All other speakers, members of the CE advisory committee and planning committee who contributed to this activity have no actual or potential conflicts of interest to disclose.

Statement of Continuing Pharmacy Education Credit:
ACPE_Logo.jpgThe University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.  This activity has been assigned ACPE Universal Activity Number 0016-0000-18-023-L01-P, for 1.0 contact hours (0.1 CEUs).  Attendance at the entire knowledge based activity, completion of the evaluation, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s).  All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact if you do not see activity information listed within 30 days.  For more information and to set up your e-Profile visit: 

Event Details

Room: Chicago:134-1; Rockford: E211

Date Posted: Wed, Sep 12
Date Updated: Wed, Sep 12

Share this event